The 3am wake-ups start first. Then the cycle shifts, the sleep stops being restorative, and the cognitive sharpness you've relied on for twenty years takes longer to find in the afternoon.
Bioidentical Hormone Replacement Therapy (BHRT) at Sante Health is a medically supervised program that restores estradiol, progesterone, and (when clinically indicated) testosterone to optimized physiological ranges, using a comprehensive endocrine panel, conservative titration, and multiple delivery options matched to where you are in your hormonal transition.
Hormonal shifts in perimenopause and menopause layer in over months, not days. The signals are specific. If several of these resonate, a comprehensive hormone panel is a reasonable next step.
Most women on optimized BHRT don't describe feeling younger. They describe a steadying: sleep returns, the fog lifts, and the body starts responding again.
Waking at 2 or 3am and struggling to fall back asleep, even when nothing is wrong
Hot flashes or night sweats that disrupt sleep or interrupt your day
Cycle changes before menopause: shorter, longer, heavier, or unpredictable
Mood shifts that feel out of character, including new irritability or low-grade anxiety
Bioidentical Hormone Replacement Therapy is a medically supervised program that restores estradiol, progesterone, and (when clinically appropriate) testosterone to optimized physiological ranges through carefully titrated hormone administration. "Bioidentical" means the hormones used are molecularly identical to the hormones your body produces, sourced from a trusted compounding pharmacy when custom formulations are needed. This is a different molecule class than horse-derived conjugated estrogens (e.g., Premarin) and different again from the synthetic progestins used in older oral contraceptives.
Where a standard pellet shop runs a short panel and inserts on a fixed cadence, Sante's assessment is a full endocrine workup. The initial panel includes estradiol (E2), progesterone, total and free testosterone, sex hormone-binding globulin (SHBG), DHEA-S, FSH, LH, a complete thyroid panel (TSH, free T3, free T4, reverse T3, antibodies), cortisol with diurnal pattern, fasting insulin and HbA1c, lipid panel with particle detail, inflammatory markers, vitamin D, and ferritin.
You may be a good candidate for BHRT if you are a woman roughly 35 to 75 navigating perimenopause, menopause, or earlier hormonal shifts, and you have persistent symptoms (sleep disruption, hot flashes, mood or cognitive changes, libido changes, cycle irregularity, weight resistance, vaginal dryness) that have held for months despite reasonable sleep, training, and nutrition. Metabolic health, thyroid function, stress physiology, sleep, and current medications are all reviewed before therapy is initiated.
BHRT may warrant closer evaluation, or a different starting point, if you have a personal history of hormone-sensitive cancers (breast, uterine, ovarian), active or recent blood-clotting conditions, undiagnosed abnormal uterine bleeding, or are pregnant or breastfeeding. These are conversations, not hard exclusions for everyone, and the right path depends on your full clinical picture.
The right next step is a consultation to review your symptoms, your goals, and whether a comprehensive panel is indicated. Book Women's Hormone Consultation →
Every Sante program moves through the same five-stage process, the ADORE Framework, adapted to the clinical question in front of you.
A 90-minute telehealth intake reviews your symptoms, medical and gynecologic history, medications, sleep, cycle history, and goals. A comprehensive hormone and metabolic panel is ordered to a draw site near you.
Results are interpreted in context, not against a generic reference range. We explain what each marker indicates, where the pattern points, and what it means for your specific transition phase.
If BHRT is indicated, we build a plan together: delivery method (cream, pellet, or sublingual), starting dose, ancillary support if clinically warranted, and a realistic timeline. Most women feel early shifts in sleep and mood within 4 to 6 weeks, with more durable benefits at 10 to 12 weeks.
Follow-up visits run 30 to 45 minutes. Labs are repeated at 6 to 8 weeks, then at 3 and 6 months, then annually once stable. Dose, delivery, and ancillary support are titrated based on symptoms and data, not on a fixed schedule.
You understand your panel, your trajectory, and the reasoning behind every adjustment. The goal is an optimized, durable plan you can maintain with confidence as your body continues to change.
Most BHRT visits at Sante are conducted via secure telehealth. Initial consultation, results review, and follow-ups happen on a HIPAA-compliant platform. Labs are drawn at a convenient local site, and topical creams and sublingual formulations are administered at home with clear instructions and clinician support. The one in-office exception is Hormone Pellet Therapy, which requires a brief insertion at our Westlake Village location every three to six months. For women who travel often or prefer not to manage daily dosing, pellets are a low-maintenance option worth discussing at consultation.
Sante Health is led by Lovelle Valencia, a board-certified Nurse Practitioner (NP, FNP, PMHNP) with specialized training in functional medicine (IFM), metabolic health (A4M), and psychiatric mental health. Care is delivered through evidence-based protocols designed to address root metabolic drivers, not just symptoms.
Women's hormone optimization sits at the intersection of all three disciplines. Estradiol, progesterone, and testosterone interact directly with mood, sleep, cognition, and metabolic function, so a perimenopausal or menopausal evaluation is rarely just a hormone question. The PMHNP training matters here: cognitive and mood symptoms get the same clinical attention as hot flashes or cycle changes. Prescribing, labs, and titration decisions are made by Lovelle directly, not a sales protocol. Every BHRT plan is anchored in your specific panel, your transition phase, and your risk profile.
Professional affiliations: AANP, ANCC, A4M, IFM.
Meet Your Provider →
Sante Health is a cash-pay practice. Superbills can be provided on request for select visit types so you can submit to your insurance carrier for potential out-of-network reimbursement.
Compounded hormone preparations and pellet costs are billed separately and reviewed transparently at your initial visit. Accepted payment methods include Visa, MasterCard, Discover, American Express, Apple Pay, Google Pay, PayPal, and Zelle.
If you're a woman in perimenopause, menopause, or earlier hormonal shifts with persistent symptoms (sleep disruption, hot flashes, mood or cognitive changes, libido changes, weight resistance) and those symptoms have held for months despite reasonable sleep, training, and nutrition, a comprehensive hormone panel is a reasonable next step. A consultation determines whether labs and BHRT are clinically appropriate for you.
Topical creams are applied daily and allow precise dose titration. Sublingual formulations dissolve under the tongue, offering a needle-free option with steady absorption. Pellets are inserted in-office every three to six months for hands-off, sustained delivery. The right choice depends on your lifestyle, your transition phase, and how your body responds. We decide together at consultation.
Most women report early changes in sleep, mood, and hot flash frequency within 4 to 6 weeks of starting an optimized protocol. More durable benefits (cognitive clarity, libido, body composition, joint comfort) typically consolidate between 10 and 12 weeks, when follow-up labs also guide any dose refinement.
The comprehensive panel evaluates estradiol, progesterone, total and free testosterone, SHBG, DHEA-S, FSH, LH, a full thyroid panel, cortisol with diurnal pattern, fasting insulin, HbA1c, lipids with particle detail, inflammatory markers, vitamin D, and ferritin. This breadth distinguishes a root-cause evaluation from a single-number workup.
Sante operates as a cash-pay practice. Superbills can be provided for eligible visits, which some patients submit for potential out-of-network reimbursement. Coverage for compounded hormones varies significantly by carrier and is best verified directly with your plan.
BHRT carries known risks, including effects on breast and uterine tissue, mood and cycle changes during titration, and (for women with relevant history) considerations around clotting risk. We screen for personal and family history of hormone-sensitive cancers, evaluate cardiovascular and clotting risk factors, and monitor through scheduled follow-up labs. Conservative dosing and close follow-up are how risk stays managed.
A considered decision deserves a real conversation, not a questionnaire. Book a consultation to review your symptoms, order a comprehensive panel, and build a plan that makes sense for your body and where you are in your transition.
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare provider for personalized guidance.
